{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:00:41Z","timestamp":1783116041087,"version":"3.54.6"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-024-03191-y","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T09:02:11Z","timestamp":1721120531000},"page":"1797-1807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic role of late gadolinium-enhanced MRI in confirmed and suspected cardiac sarcoidosis: meta-analysis"],"prefix":"10.1007","volume":"40","author":[{"given":"Ryusuke","family":"Sekii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Horita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"key":"3191_CR1","doi-asserted-by":"crossref","unstructured":"Tana C, Donatiello I, Caputo A et al Clinical features, histopathology and differential diagnosis of Sarcoidosis. Cells 2021;11.","DOI":"10.3390\/cells11010059"},{"key":"3191_CR2","first-page":"2663","volume":"38","author":"DH Birnie","year":"2017","unstructured":"Birnie DH, Kandolin R, Nery PB, Kupari M (2017) cardiac manifestations of sarcoidosis: diagnosis and management. Eur Heart J 38:2663\u20132670","journal-title":"Eur Heart J"},{"key":"3191_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.15420\/aer.2020.09","volume":"9","author":"N Gilotra","year":"2020","unstructured":"Gilotra N, Okada D, Sharma A, Chrispin J (2020) Management of cardiac sarcoidosis in 2020. Arrhythm Electrophysiol Rev 9:182\u2013188","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"3191_CR4","first-page":"50","volume":"6","author":"E Hulten","year":"2016","unstructured":"Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R (2016) Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther 6:50\u201363","journal-title":"Cardiovasc Diagn Ther"},{"key":"3191_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1148\/radiol.213170","volume":"304","author":"M Aitken","year":"2022","unstructured":"Aitken M, Chan MV, Urzua Fresno C et al (2022) Diagnostic accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: a systematic review and Meta-analysis. Radiology 304:566\u2013579","journal-title":"Radiology"},{"key":"3191_CR6","doi-asserted-by":"publisher","first-page":"e005001","DOI":"10.1161\/CIRCIMAGING.116.005001","volume":"9","author":"E Hulten","year":"2016","unstructured":"Hulten E, Agarwal V, Cahill M et al (2016) Presence of Late Gadolinium Enhancement by Cardiac magnetic resonance among patients with suspected Cardiac Sarcoidosis is Associated with adverse Cardiovascular prognosis: a systematic review and Meta-analysis. Circ Cardiovasc Imaging 9:e005001","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"3191_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","volume":"10","author":"GC Coleman","year":"2017","unstructured":"Coleman GC, Shaw PW et al (2017) Prognostic value of myocardial scarring on CMR in patients with Cardiac Sarcoidosis. JACC Cardiovasc Imaging 10(4):411\u2013420","journal-title":"JACC Cardiovasc Imaging"},{"key":"3191_CR8","doi-asserted-by":"publisher","first-page":"e222483","DOI":"10.1148\/radiol.222483","volume":"307","author":"M Aitken","year":"2023","unstructured":"Aitken M, Davidson M, Chan MV et al (2023) Prognostic value of Cardiac MRI and FDG PET in Cardiac Sarcoidosis: a systematic review and Meta-analysis. Radiology 307:e222483","journal-title":"Radiology"},{"key":"3191_CR9","doi-asserted-by":"crossref","unstructured":"Pontone G, Guaricci AI, Andreini D et al Prognostic Benefit of Cardiac magnetic resonance over Transthoracic Echocardiography for the Assessment of ischemic and nonischemic dilated cardiomyopathy patients referred for the evaluation of primary Prevention Implantable cardioverter-defibrillator therapy. Circ Cardiovasc Imaging 2016;9.","DOI":"10.1161\/CIRCIMAGING.115.004956"},{"key":"3191_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jcmg.2022.10.018","volume":"16","author":"A Stevenson","year":"2023","unstructured":"Stevenson A, Bray JJH, Tregidgo L et al (2023) Prognostic value of late Gadolinium Enhancement detected on Cardiac magnetic resonance in cardiac sarcoidosis. JACC Cardiovasc Imaging 16:345\u2013357","journal-title":"JACC Cardiovasc Imaging"},{"key":"3191_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jcmg.2022.11.012","volume":"16","author":"J Wang","year":"2023","unstructured":"Wang J, Zhang J, Hosadurg N et al (2023) Prognostic value of RV abnormalities on CMR in patients with known or suspected Cardiac Sarcoidosis. JACC Cardiovasc Imaging 16:361\u2013372","journal-title":"JACC Cardiovasc Imaging"},{"key":"3191_CR12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"3191_CR13","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F et al (2014) HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11:1305\u20131323","journal-title":"Heart Rhythm"},{"key":"3191_CR14","first-page":"768","volume":"46","author":"K Sugisaki","year":"2008","unstructured":"Sugisaki K (2008) [Diagnostic guidelines and Criteria for Sarcoidosis\u20132006]. Nihon Kokyuki Gakkai Zasshi 46:768\u2013780","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"3191_CR15","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","volume":"83","author":"A Fumio Terasaki","year":"2019","unstructured":"Fumio Terasaki A, Azuma T, Anzai et al (2019) JCS 2016 Guideline on diagnosis and treatment of Cardiac Sarcoidosis. Circ J 83:2329\u20132388","journal-title":"Circ J"},{"key":"3191_CR16","doi-asserted-by":"publisher","first-page":"iii","DOI":"10.3310\/hta7270","volume":"7","author":"JJ Deeks","year":"2003","unstructured":"Deeks JJ, Dinnes J, D\u2019Amico R et al (2003) Evaluating non-randomised intervention studies. Health Technol Assess 7:iii\u2013x","journal-title":"Health Technol Assess"},{"key":"3191_CR17","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"3191_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/sim.6342","volume":"34","author":"ZC Jin","year":"2015","unstructured":"Jin ZC, Zhou XH, He J (2015) Statistical methods for dealing with publication bias in meta-analysis. Stat Med 34:343\u2013360","journal-title":"Stat Med"},{"key":"3191_CR19","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ijcard.2016.07.233","volume":"222","author":"L Agoston-Coldea","year":"2016","unstructured":"Agoston-Coldea L, Kouaho S, Sacre K et al (2016) High mass (>\u200918\u00a0g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis. Int J Cardiol 222:950\u2013956","journal-title":"Int J Cardiol"},{"key":"3191_CR20","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/jamacardio.2022.2981","volume":"7","author":"PSS Athwal","year":"2022","unstructured":"Athwal PSS, Chhikara S, Ismail MF et al (2022) Cardiovascular Magnetic Resonance Imaging Phenotypes and long-term outcomes in patients with suspected Cardiac Sarcoidosis. Jama Cardiol 7:1057\u20131066","journal-title":"Jama Cardiol"},{"key":"3191_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ijcard.2017.03.033","volume":"241","author":"PE Bravo","year":"2017","unstructured":"Bravo PE, Raghu G, Rosenthal DG et al (2017) Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging. Int J Cardiol 241:457\u2013462","journal-title":"Int J Cardiol"},{"key":"3191_CR22","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/CIRCEP.113.000156","volume":"7","author":"T Crawford","year":"2014","unstructured":"Crawford T, Mueller G, Sarsam S et al (2014) Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias. Circ Arrhythm Electrophysiol 7:1109\u20131115","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"3191_CR23","doi-asserted-by":"crossref","unstructured":"Ekstr\u00f6m K, Lehtonen J, H\u00e4nninen H, Kandolin R, Kivist\u00f6 S, Kupari M (2016) Magnetic Resonance Imaging as a predictor of Survival Free of Life-threatening arrhythmias and transplantation in Cardiac Sarcoidosis. J Am Heart Assoc ;5","DOI":"10.1161\/JAHA.115.003040"},{"key":"3191_CR24","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1007\/s00330-020-06765-1","volume":"30","author":"L Flamee","year":"2020","unstructured":"Flamee L, Symons R, Degtiarova G et al (2020) Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis. Eur Radiol 30:3702\u20133710","journal-title":"Eur Radiol"},{"key":"3191_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.amjcard.2020.08.007","volume":"134","author":"Z Gowani","year":"2020","unstructured":"Gowani Z, Habibi M, Okada DR et al (2020) Utility of Cardiac magnetic resonance imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for ventricular arrhythmias in patients with Cardiac Sarcoidosis. Am J Cardiol 134:123\u2013129","journal-title":"Am J Cardiol"},{"key":"3191_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","volume":"6","author":"S Greulich","year":"2013","unstructured":"Greulich S, Deluigi CC, Gloekler S et al (2013) CMR Imaging predicts death and other adverse events in suspected Cardiac Sarcoidosis. Jacc-Cardiovascular Imaging 6:501\u2013511","journal-title":"Jacc-Cardiovascular Imaging"},{"key":"3191_CR27","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/heartjnl-2013-305187","volume":"100","author":"T Ise","year":"2014","unstructured":"Ise T, Hasegawa T, Morita Y et al (2014) Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. Heart 100:1165\u20131172","journal-title":"Heart"},{"key":"3191_CR28","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1007\/s00392-019-01591-y","volume":"109","author":"Y Kagioka","year":"2020","unstructured":"Kagioka Y, Yasuda M, Okune M et al (2020) Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging. Clin Res Cardiol 109:988\u2013998","journal-title":"Clin Res Cardiol"},{"key":"3191_CR29","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","volume":"10","author":"V Kouranos","year":"2017","unstructured":"Kouranos V, Tzelepis GE, Rapti A et al (2017) Complementary role of CMR to conventional screening in the diagnosis and prognosis of Cardiac Sarcoidosis. Jacc-Cardiovascular Imaging 10:1437\u20131447","journal-title":"Jacc-Cardiovascular Imaging"},{"key":"3191_CR30","first-page":"9","volume":"61","author":"K Matsumoto","year":"2015","unstructured":"Matsumoto K, Ehara S, Sakaguchi M et al (2015) Clinical characteristics of late Gadolinium Enhancement in patients with Cardiac Sarcoidosis. Osaka City Med J 61:9\u201317","journal-title":"Osaka City Med J"},{"key":"3191_CR31","doi-asserted-by":"crossref","unstructured":"Murtagh G, Laffin LJ, Beshai JF et al (2016) Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection Fraction Risk Stratification using Cardiovascular magnetic resonance. Circulation-Cardiovascular Imaging ;9","DOI":"10.1161\/CIRCIMAGING.115.003738"},{"key":"3191_CR32","first-page":"634","volume":"16","author":"J Nadel","year":"2015","unstructured":"Nadel J, Lancefield T, Voskoboinik A, Taylor AJ (2015) Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death. Eur Heart Journal-Cardiovascular Imaging 16:634\u2013641","journal-title":"Eur Heart Journal-Cardiovascular Imaging"},{"key":"3191_CR33","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1378\/chest.14-0139","volume":"146","author":"T Nagai","year":"2014","unstructured":"Nagai T, Kohsaka S, Okuda S, Anzai T, Asano K, Fukuda K (2014) Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without Cardiac Manifestation. Chest 146:1064\u20131072","journal-title":"Chest"},{"key":"3191_CR34","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1111\/jce.14082","volume":"30","author":"DR Okada","year":"2019","unstructured":"Okada DR, Xie E, Assis F et al (2019) Regional abnormalities on cardiac magnetic resonance imaging and arrhythmic events in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol 30:1967\u20131976","journal-title":"J Cardiovasc Electrophysiol"},{"key":"3191_CR35","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","volume":"120","author":"MR Patel","year":"2009","unstructured":"Patel MR, Cawley PJ, Heitner JF et al (2009) Detection of myocardial damage in patients with sarcoidosis. Circulation 120:1969\u20131977","journal-title":"Circulation"},{"key":"3191_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ehf2.12201","volume":"5","author":"JP Smedema","year":"2018","unstructured":"Smedema JP, van Geuns RJ, Ector J, Heidbuchel H, Ainslie G, Crijns H (2018) Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis. ESC Heart Fail 5:157\u2013171","journal-title":"ESC Heart Fail"},{"key":"3191_CR37","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.jcmg.2019.12.011","volume":"13","author":"PS Velangi","year":"2020","unstructured":"Velangi PS, Chen KA, Kazmirczak F et al (2020) Right ventricular abnormalities on Cardiovascular Magnetic Resonance Imaging in patients with sarcoidosis. JACC Cardiovasc Imaging 13:1395\u20131405","journal-title":"JACC Cardiovasc Imaging"},{"key":"3191_CR38","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/ehjci\/jex340","volume":"19","author":"EC Wicks","year":"2018","unstructured":"Wicks EC, Menezes LJ, Barnes A et al (2018) Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging 19:757\u2013767","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"3191_CR39","doi-asserted-by":"publisher","first-page":"e000437","DOI":"10.1136\/openhrt-2016-000437","volume":"3","author":"M Yasuda","year":"2016","unstructured":"Yasuda M, Iwanaga Y, Kato T et al (2016) Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with cardiac sarcoidosis. Open Heart 3:e000437","journal-title":"Open Heart"},{"key":"3191_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1536\/ihj.21-635","volume":"63","author":"K Yodogawa","year":"2022","unstructured":"Yodogawa K, Fukushima Y, Tachi M et al (2022) Localization of late Gadolinium Enhancement and its association with ventricular tachycardia in patients with Cardiac Sarcoidosis. Int Heart J 63:235\u2013240","journal-title":"Int Heart J"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-024-03191-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-024-03191-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-024-03191-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T04:06:32Z","timestamp":1726286792000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-024-03191-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3191"],"URL":"https:\/\/doi.org\/10.1007\/s10554-024-03191-y","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]},"assertion":[{"value":"25 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"IRB approval was not obtained, as this study was a meta-analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}